David J. Sourdive
Co-Founder, Deputy CEO, Executive VP of CMC & Manufacturing and DirectorDr. David J. Sourdive, Ph.D., is Independent Director of Exeliom Biosciences. Dr. Sourdive, is a venture partner at Elaia Partners. He is co-founder of Cellectis S.A. and has held the position of Executive Vice President, CMC and Manufacturing since 2021. He also serves as Deputy Chief Executive Officer at Cellectis S.A. He served as an Executive Vice President of Strategic Initiatives of Cellectis SA since 2019 until November 2021 and served as its Executive Vice President of Technical Operations since February 6, 2017 until 2019. He served as its Executive Vice President of Corporate Development at Cellectis S.A. since 2008 until February 6, 2017. He is a member of the board of directors of Exeliom S.A.S. since September 2019, Cell-Easy S.A.S since February 2021 and Mablink SAS since April 2021. From December 2018 to December 2021, he has served on the board of directors of Enobraq SAS. He served as the President of Ectycell, a subsidiary of Cellectis. He served as the Head of the Treat Yourself Better initiative at Cellectis SA since May 2013. He served as the Head of Biotechnology Laboratory at the Centre d'Etudes du Bouchet (French Ministry of Defense). Dr. Sourdive was heading a research group in Immunology at the Pasteur Institute. He has been a Director at Cellectis SA since 2000. He applied recombination tracking technologies to anti-viral immune memory, at the Emory University Vaccine Center in Atlanta. From 1997 to 1998, He worked at one of the leading laboratories in viral immunology at Emory University in Atlanta, Georgia. Since February 2014, he has also served on the board of directors of Mediterranean Institute for Life Sciences. Since June 2015 until December 2019, he has served on the board of directors of Eukarÿs SAS. He served on the Board of Omics SAS from 2017 to May 2020. He also has management training from the HEC (Challenge +). He previously served on the boards of directors of Cellectis AB, Medicen Paris Region and Seine Saint Denis Avenir. From 1998 to 2000, he directed the biotechnologies laboratory of the Centre d’Etudes du Bouchet for the French Ministry of Defense. He attended Ecole Polytechnique and received a Ph.D. in Molecular Virology form University of Paris VII/ Institut Pasteur.
Positions
- Company NameCellectis S.A.Stock CodeCLLSPositionCo-Founder, Deputy CEO, Executive VP of CMC & Manufacturing and DirectorColleagues
- ACAndre ChoulikaCo-Founder, CEO & Director
- JGJean-Pierre GarnierIndependent Non-Executive Chairman
- ASArthur StrilCFO & Chief Business Officer
- VCValerie CrosPrincipal Financial Officer & Principal Accounting Officer
- JCJean Charles EpinatChief Technological Officer
- ACAndre C. MullerIndependent Director
- LALaurent ArthaudDirector
